Neurotoxic effects of postnatal thimerosal are mouse strain dependent

The developing brain is uniquely susceptible to the neurotoxic hazard posed by mercurials. Host differences in maturation, metabolism, nutrition, sex, and autoimmunity influence outcomes. How population-based variability affects the safety of the ethylmercury-containing vaccine preservative, thimerosal, is unknown. Reported increases in the prevalence of autism, a highly heritable neuropsychiatric condition, are intensifying public focus on environmental exposures such as thimerosal. Immune profiles and family history in autism are frequently consistent with autoimmunity. We hypothesized that autoimmune propensity influences outcomes in mice following thimerosal challenges that mimic routine childhood immunizations. Autoimmune disease-sensitive SJL/J mice showed growth delay; reduced locomotion; exaggerated response to novelty; and densely packed, hyperchromic hippocampal neurons with altered glutamate receptors and transporters. Strains resistant to autoimmunity, C57BL/6J and BALB/cJ, were not susceptible. These findings implicate genetic influences and provide a model for investigating thimerosal-related neurotoxicity.

[1]  S. Dowell,et al.  Recommended childhood immunization schedule-United States, January-December 2001. Committee on Infectious Diseases. , 2001, Pediatrics.

[2]  J. Nielsen,et al.  Methyl mercuric chloride toxicokinetics in mice. I: Effects of strain, sex, route of administration and dose. , 1991, Pharmacology & toxicology.

[3]  K. Pollard,et al.  Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. , 1992, Clinical immunology and immunopathology.

[4]  J. Olney,et al.  New insights and new issues in developmental neurotoxicology. , 2002, Neurotoxicology.

[5]  A. Pestronk,et al.  Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. , 1999, The Journal of pediatrics.

[6]  J. Altman,et al.  Postnatal development of locomotion in the laboratory rat , 1975, Animal Behaviour.

[7]  A. Oskarsson,et al.  Risk assessment in relation to neonatal metal exposure. , 1998, The Analyst.

[8]  P. Hultman,et al.  Dose-response study of thimerosal-induced murine systemic autoimmunity. , 2004, Toxicology and applied pharmacology.

[9]  J. Nielsen,et al.  Mercury-induced autoimmunity in mice. , 2002, Environmental health perspectives.

[10]  E. Fombonne,et al.  Pervasive developmental disorders in preschool children. , 2001, JAMA.

[11]  P. Koch,et al.  Homozygous gene deletions of the glutathione S-transferases M1 and T1 are associated with thimerosal sensitization , 2000, International archives of occupational and environmental health.

[12]  B. Weiss,et al.  Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects. , 2001, Environmental health perspectives.

[13]  Courtney A. Harper,et al.  A genomic screen of autism: evidence for a multilocus etiology. , 1999, American journal of human genetics.

[14]  N. Sarvetnick,et al.  Cytokines: promoters and dampeners of autoimmunity. , 2002, Current opinion in immunology.

[15]  Wim E Crusio.  Genetic dissection of mouse exploratory behaviour , 2001, Behavioural Brain Research.

[16]  Rothstein,et al.  EAAC 1 , a High-affinity Glutamate Transporter , is Localized to Astrocytes and Gabaergic Neurons besides Pyramidal Cells in the Rat Cerebral Cortex , 1998 .

[17]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[18]  E. Cooper,et al.  Infections, Toxic Chemicals and Dietary Peptides Binding to Lymphocyte Receptors and Tissue Enzymes are Major Instigators of Autoimmunity in Autism , 2003, International journal of immunopathology and pharmacology.

[19]  R. Smialowicz,et al.  Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. , 2000, Environmental health perspectives.

[20]  A. Fedorov,et al.  Morphological Study of the Entorhinal Cortex, Hippocampal Formation, and Basal Ganglia in Rett Syndrome Patients , 1999, Neurobiology of Disease.

[21]  Paul Law,et al.  Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism , 1999, Journal of child neurology.

[22]  A. Torres,et al.  Strong association of the third hypervariable region of HLA-DR beta 1 with autism. , 1996, Journal of neuroimmunology.

[23]  C. Brosnan,et al.  Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias , 1999, Journal of Neuroimmunology.

[24]  A. Billiau,et al.  Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. , 1988, Journal of immunology.

[25]  B. Jortner,et al.  Methods to identify and characterize developmental neurotoxicity for human health risk assessment. II: neuropathology. , 2001, Environmental health perspectives.

[26]  A. Levey,et al.  Localization of neuronal and glial glutamate transporters , 1994, Neuron.

[27]  G. Duff,et al.  Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. , 1995, Journal of inflammation.

[28]  D. Balomenos,et al.  The prototypic Th2 autoimmunity induced by mercury is dependent on IFN-gamma and not Th1/Th2 imbalance. , 1998, Journal of immunology.

[29]  Satoshi O. Suzuki,et al.  Translocation of glutamate transporter subtype excitatory amino acid carrier 1 protein in kainic acid-induced rat epilepsy. , 2003, The American journal of pathology.

[30]  U. Lindh,et al.  Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice. , 2000, Environmental health perspectives.

[31]  Robert L Davis,et al.  Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. , 2003, Pediatrics.

[32]  J. Rothstein,et al.  Glutamate Transporter Protein Subtypes Are Expressed Differentially during Rat CNS Development , 1997, The Journal of Neuroscience.

[33]  J. Nielsen.  Toxicokinetics of mercuric chloride and methylmercuric chloride in mice. , 1992, Journal of toxicology and environmental health.

[34]  Thomas M. Aune,et al.  Cutting Edge: Molecular Portrait of Human Autoimmune Disease1 , 2002, The Journal of Immunology.

[35]  G. Hanley,et al.  Resistance to HgCl2-induced autoimmunity in haplotype-heterozygous mice is an intrinsic property of B cells. , 1998, Journal of immunology.

[36]  B. Pearce,et al.  Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. , 1992, Neurotoxicology and teratology.

[37]  Alex L Kolodkin,et al.  Curbing the Excesses of Youth Molecular Insights into Axonal Pruning , 2003, Neuron.

[38]  J. Rothstein,et al.  EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex. , 1998, Cerebral cortex.

[39]  R. Burger,et al.  DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. , 1995, Neuropsychobiology.

[40]  P. Hultman,et al.  Methyl mercury-induced autoimmunity in mice. , 1999, Toxicology and applied pharmacology.

[41]  J. Lopreiato,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[42]  Adele Cutler,et al.  The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. , 2002, Human immunology.

[43]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[44]  S. Selvin,et al.  The Changing Prevalence of Autism in California , 2002, Journal of autism and developmental disorders.

[45]  J. Mason,et al.  Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal , 2004, Molecular Psychiatry.

[46]  W. Spitzer,et al.  Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), The Changing Prevalence of Autism in California , 2003, Journal of autism and developmental disorders.

[47]  P. Schauwecker.  Modulation of Cell Death by Mouse Genotype: Differential Vulnerability to Excitatory Amino Acid-Induced Lesions , 2002, Experimental Neurology.

[48]  K. Behar,et al.  A Neuronal Glutamate Transporter Contributes to Neurotransmitter GABA Synthesis and Epilepsy , 2002, The Journal of Neuroscience.

[49]  V. Singh,et al.  Antibodies to Myelin Basic Protein in Children with Autistic Behavior , 1993, Brain, Behavior, and Immunity.

[50]  Ruth A. Carper,et al.  Unusual brain growth patterns in early life in patients with autistic disorder , 2001, Neurology.

[51]  A. García,et al.  Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis , 2001, Neuroscience.

[52]  P. V. van Rijen,et al.  Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. , 2002, Brain : a journal of neurology.

[53]  Gereon R. Fink,et al.  Postnatal development of forebrain regions in the autoimmune NZB-mouse , 1991, Anatomy and Embryology.

[54]  J. Swann,et al.  Developmental alterations in the sensitivity of hippocampal NMDA receptors to AP5. , 1994, Brain research. Developmental brain research.

[55]  G. Buzsáki,et al.  Alterations in [3H]kainate and N-methyl-d-aspartate-sensitive l-[3H]-glutamate binding in the rat hippocampal formation following fimbria-fornix lesions , 1992, Experimental Neurology.

[56]  A. Torres,et al.  Strong association of the third hypervariable region of HLA-DRβ1 with autism , 1996, Journal of Neuroimmunology.

[57]  K. Pollard,et al.  Murine susceptibility to mercury. II. autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice. , 1993, Clinical immunology and immunopathology.

[58]  D. Rice,et al.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. , 2000, Environmental health perspectives.

[59]  L. Hood,et al.  Revised nomenclature of mouse H-2 genes. , 1990, Immunogenetics.

[60]  D. Hillman,et al.  Distribution of glutamate receptors GluR 2/3 and NR1 in the developing rat cerebellum , 1997, Neuroscience.

[61]  T. Owens,et al.  Interferon‐γ confers resistance to experimental allergic encephalomyelitis , 1996, European journal of immunology.

[62]  C. Rice,et al.  Prevalence of autism in a US metropolitan area. , 2003, JAMA.

[63]  G. Möller,et al.  Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity. , 2000, International immunology.

[64]  J. Todd,et al.  New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. , 1998, Journal of immunology.

[65]  U. Johansson,et al.  The Genotype Determines the B Cell Response in Mercury–Treated Mice , 1998, International Archives of Allergy and Immunology.

[66]  L. Croen,et al.  Response: A Response to Blaxill, Baskin, and Spitzer on Croen et al. (2002), “The Changing Prevalence of Autism in California” , 2003 .

[67]  C. McDougle,et al.  Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. , 2003, Pediatrics.

[68]  A. Yasutake,et al.  Sex and age differences in mercury distribution and excretion in methylmercury-administered mice. , 1986, Journal of toxicology and environmental health.

[69]  L. Magos,et al.  The comparative toxicology of ethyl- and methylmercury , 1985, Archives of Toxicology.

[70]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[71]  Robert T. Chen,et al.  A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. , 2003, Pediatrics.

[72]  T. Kemper,et al.  Microscopic Observations of the Brain in Rett Syndrome , 1995, Neuropediatrics.

[73]  J. Olney,et al.  Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. , 1999, Science.

[74]  P. Schwartzkroin,et al.  Inhibition in kainate-lesioned hyperexcitable hippocampi: physiologic, autoradiographic, and immunocytochemical observations , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[75]  J. Nielsen,et al.  The effect of toxicokinetics on murine mercury-induced autoimmunity. , 1998, Environmental research.